Every compound, in full light.
22 research-grade peptides. Verified ≥99.0% purity, third-party testing, and a published certificate for every lot.
Triple GIP, GLP-1, and glucagon receptor agonist studied in metabolic and energy-balance research.
Dual GIP and GLP-1 receptor agonist widely used in incretin-pathway research.
Long-acting GLP-1 receptor agonist analogue used in metabolic signalling studies.
Long-acting amylin analogue investigated alongside incretin agonists in satiety research.
Modified C-terminal fragment of human growth hormone studied in lipolysis models.
Selective growth hormone secretagogue receptor agonist with a well-characterised profile.
Modified GRF (1-29) analogue used in growth-hormone-releasing pathway research.
Stabilised GHRH analogue studied in adipose tissue and endocrine research.
Synthetic GHRH (1-29) fragment and a reference compound in somatotropic axis studies.
Pentadecapeptide of gastric origin extensively investigated in tissue repair models.
Synthetic thymosin beta-4 fragment studied in angiogenesis and cell migration research.
A 28-amino-acid peptide widely studied for its role in immune modulation.
Heptapeptide ACTH (4-7) analogue investigated in neuroplasticity and cognition models.
Tuftsin-derived anxiolytic peptide studied in stress-response and neurochemistry research.
A single-vial pairing of Selank and Semax, 10 mg of each, for comparative neuropeptide study designs.
Synthetic tetrapeptide AEDG investigated in telomerase and cellular aging research.
Mitochondrial-derived peptide studied in metabolic homeostasis and cellular stress models.
Mitochondria-targeted tetrapeptide studied in cardiolipin binding and bioenergetics research.
Endogenous tripeptide central to cellular redox research and oxidative stress models.
Copper tripeptide complex extensively studied in dermal remodelling research.
Cyclic melanocortin receptor agonist analogue used in pigmentation pathway research.
Melanocortin receptor agonist and metabolite of Melanotan II, studied in receptor research.